Eurasia Invest Ltd.
5
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
The Sublimated Mare Milk Supplement in Hepatitis C
Role: collaborator
The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics
Role: collaborator
Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients
Role: collaborator
Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis
Role: collaborator
Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis
Role: collaborator
All 5 trials loaded